Modifier genes in mice and humans

Nature Reviews Genetics

Volumn 2, Issue 3, 2001, Pages 165-174

  Nadeau, Joseph H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CFTR PROTEIN, HUMAN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL; GENE EXPRESSION; GENETIC DISORDER; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETICS; GENOME IMPRINTING; GENOTYPE; HUMAN; MEDICAL GENETICS; MOUSE; MUTATION; PENETRANCE; PHENOTYPE; REVIEW;

ANIMALS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE EXPRESSION; GENETIC DISEASES, INBORN; GENETICS, MEDICAL; GENOMIC IMPRINTING; GENOTYPE; HUMANS; LINKAGE (GENETICS); MICE; MUTATION; PENETRANCE; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0035287508     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/35056009     Document Type: Review

References (86)

1. Bridges, C. B. Specific modifiers of eosin eye color in Drosophila melanogaster. J. Exp. Zool. 10, 337-384 (1919).
2. Gruneberg, H. The Pathology of Development (John Wiley, New York, 1950).
3. Romeo, G. & McKusick, V. A. Phenotypic diversity, allelic series and modifier genes. Nature Genet. 7, 451-453 (1994).
4. Scriver, C. R. & Waters, P. J. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet. 15, 267-272 (1999).
5. Dipple, K. M. & McCabe, E. R. B. Phenotypes of patients with 'simple' Mendelian disorders are complex traits: thresholds, modifiers, and system dynamics. Am. J. Hum. Genet. 66, 1729-1735 (2000).
6. Feingold, J. Les genes modificateurs dans les maladies hereditaires. Medicine/sciences 16, 1-5 (2000).
7. Davis, A. & Justice, M. J. Mouse alleles: if you've seen one, you haven't seen them all. Trends Genet. 14, 438-441 (1998).
8. McGue, M. & Bouchard, T. J. Genetic and environmental influences on human behavioral differences. Annu. Rev. Neurosci. 21, 1-24 (1998).
9. Cookson, W. The alliance of genes and environment in asthma and allergy. Nature 402, B5-B11 (1999).
10. Perusse, L. & Bouchard, C. Genotype-environment interaction in human obesity. Nutr. Rev. 57, S31-S37 (1999).
11. Shields, P. G. & Harris, C. C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J. Clin. Oncol. 18, 2309-2315 (2000).
12. Fields, S. & Sternglanz, R. The two-hybrid system: an assay for protein-protein interactions. Trends Genet. 10, 286-292 (1994).
13. Husi, H. et al. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nature Neurosci. 3, 661-669 (2000).
14. King, R. C. & Stansfield, W. D. A Dictionary of Genetics (Oxford Univ. Press, Oxford, 1990).
15. Phillips, P. C. The language of gene interaction. Genetics 149, 1167-1171 (1998).
16. Hummel, K. P. The inheritance and expression of Disorganization, an unusual mutation in the mouse. J. Exp. Zool. 137, 389-423 (1958).
17. Hummel, K. P. Developmental anomalies in mice resulting from action of the gene, Disorganization, a semi-dominant lethal. Pediatrics 23, 212-221 (1959).
18. Crosby, J. L., Varnum, D. S. & Nadeau, J. H. Two-hit model for sporadic congenital anomalies in mice with the disorganization mutation. Am. J. Hum. Genet. 52, 866-674 (1993). This paper shows how birth defects with sporadic features can be accounted for by the random occurrence of adverse events in somatic tissues, as occurs in many cancers.
19. Gruneberg, H. Genetic studies on the skeleton of the mouse. II. Minor variations of the vertebral column. J. Genet. 50, 112-141 (1950c).
20. Gruneberg, H. Genetical studies on the skeleton of the mouse. XV. Relations between major and minor variants. J. Genet. 53, 515-535 (1955).
21. Noben-Trauth, K., Zheng, Q. Y., Johnson, K. R. & Nishina, P. M. mdfw: a deafness susceptibility locus that interacts with deaf waddler (dfw). Genomics 44, 266-272 (1997).
22. Dobrovolskaia-Zavadskaia, N. Sur une novelle mutation de la queue, 'queue filiforme', chez la souris. C. R. Soc. Biol. Paris 97, 1140-1142 (1927).
23. Dunn, L. C. Changes in the degree of dominance of factors affecting tail-length in the house mouse. Am. Nat. 76, 552-569 (1942).
24. Cox, G. A. et al. The mouse fidgetin gene defines a new role for AAA family proteins in mammalian development. Nature Genet. 26, 198-202 (2000).
25. Gruneberg, H. Two new mutant genes in the house mouse. J. Genet. 45, 22-28 (1943).
26. Konyukhov, B. V. & Mironova, O. V. Interaction of the mutant genes splotch and fidget in mice. Sov. Genet. 15, 553-562 (1979).
27. Wilson, D. B. Proliferation of the neural tube of the Splotch (Sp) mutant mouse. J. Comp. Neurol. 154, 249-256 (1974).
28. Sweet, H. O. Dilute suppressor, a new suppressor gene in the house mouse. J. Hered. 74, 305-306 (1983).
29. Moore, K. J., Swing, D. A., Copeland, N. G. & Jenkins, N. A. Interaction of the murine dilute suppressor gene (dsu) with fourteen color mutations. Genetics 125, 421-430 (1990).
30. Moore, K. J. et al. The murine dilute suppressor gene dsu suppresses the coat-color phenotype of three pigment mutations that alter melanocyte morphology, d, ash, and In. Genetics 119, 933-941 (1988). References 29 and 30 discuss the characterization of one of the few known suppressor mutations in mice.
31. Ikeda, A. et al. Genetic modification of hearing in tubby mice: evidence for the existence of a major gene (moth1) which protects tubby mice from hearing loss. Hum. Mol. Genet. 8, 1761-1767 (1999).
32. Helwig, U. et al. Interaction between undulated and Patch leads to an extreme form of spina bifida in double-mutant mice. Nature Genet 11, 60-63 (1995).
33. Smith, E. A. et al. Mouse platelet-derived growth factor receptor-α gene is deleted in W19H and patch mutations on chromosome 5. Proc. Natl Acad. Sci. USA 88, 4811-4815 (1991).
34. Balling, R. et al. Undulated, a mutation affecting the development of the mouse skeleton, has a point mutation in the paired box of Pax1. Cell 55, 531-555 (1988).
35. Gruneberg, H. & Truslove, G. Two closely linked genes in the mouse. Genet. Res. 1, 69-90 (1960).
36. Payne, J., Shibasaki, F. & Mercola, M. Spina bifida occulta in homozygous Patch mouse embryos. Dev. Dynam. 209, 105-116 (1997).
37. Wright, M. E. Undulated, a new genetic factor in Mus musculus affecting the spine and tail. Heredity 1, 137-141 (1947).
38. Gruneberg, H. Genetical studies on the skeleton of the mouse. II. Undulated and its 'modifiers'. J. Genet. 50, 142-173 (1950).
39. Russell, W. L. Splotch, a new mutation in the house mouse, Mus musculus. Genetics 32, 102 (1947). [LAST PAGE?]
40. Epstein, D. J., Vekemans, M., & Gros, P. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67, 767-774 (1993).
41. Goulding, M. et al. Analysis of the Pax-3 gene in the mouse mutant Splotch. Genomes 17, 355-363 (1993).
42. Neumann, P. E. et al. Multifactorial inheritance of neural tube defects: localization of the major gene and recognition of modifiers in ct mutant mice. Nature Genet. 6, 357-362 (1994).
43. Copp, A. J. Genetic models of mammalian neural tube defects. Ciba Found. Symp. 181, 118-134 (1994).
44. Estibeiro, J. P. et al. Interactions between splotch (Sp) and curly-tail (ct) mouse mutants in the embryonic development of neural tube defects. Development 119, 113-121 (1993).
45. Riazuddin, S. et al. Dominant modifier DFNM1 suppresses recessive deafness in DFNB26. Nature Genet. 26, 431-434 (2000).
46. Bykhovskaya, Y. et al. Candidate locus for a nuclear modifier gene for maternally inherited deafness. Am. J. Hum. Genet. 66, 1905-1910 (2000).
47. Kajiwara, K., Berson, E. L. & Dryja, T. P. Digenic retinitis pigmentosa due to mutations at the unlinked peipherin/RDS and ROM1 loci. Science 264, 1604-1608 (1994). This is a classic example of digenic inheritance -when alleles of two genes are needed for the trait to appear.
48. Brown, M. L. & Goldstein, J. L. A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47 (1986).
49. Hobbs, H. et al. Evidence for a dominant gene that suppresses hyperchotesterolemia in a family with defective low density lipoprotein receptors. J. Clin. Invest. 84, 656-664 (1989).
50. Knoblauch, H. et al. A cholesterol lowering drug maps to chromosome 13q. Am. J. Hum. Genet. 66, 157-66 (2000). Although it is uncertain whether the gene(s) on chromosome 13q has a modifier or an additive effect, this paper shows the importance of studying the various ways in which traits and diseases can present, and illustrates the potential therapeutic relevance of genes that suppress clinically important phenotypes.
51. Cazeneuve, C. et al. Identification of MEFV-independent modifying genetic factors for familial mediterranean fever. Am. J. Hum. Genet. 67, 1136-1143 (2000). One of the few examples of linkage to a modifier gene in humans.
52. Booth, D. R. et al. Pyrin/marenostrin mutations in familial Mediterranean fever. Quart. J. Med. 91, 603-606 (1998).
53. Sohar, M. et al. Phenotype-genotype correlation in familial Mediterran fever: evidence for an association between Met694Val and amyloidosis. Eur. J. Hum. Genet. 7, 287-292 (1999).
54. Welsh, M. J., Ramsey, B. W., Accurso, F. & Cutting, G. R. in The Metabolic and Molecular Bases of Inherited Disease (eds Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D.) 5121-5188 (McGraw-Hill, New York, 2001).
55. Zielenski, J. & Tsui, L.-C. Cystic fibrosis: genotype and phenotype variations. Annu. Rev. Genet. 29, 777-807 (1995).
56. Zielenski, J. Genotype and phenotype in cystic fibrosis. Respiration 67, 117-133 (2000).
57. Knowles, M. R. et al. Mild cystic fibrosis in a consanguinous family. Ann. Intern. Med. 110, 1410-1417 (1989).
58. Kerem, E. et al. Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J. Pediat. 114, 767-773 (1989).
59. Kristidis, P. & Tsui, L.-C. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am. J. Hum. Genet. 50, 1178-1184 (1992).
60. Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. W. Engl. J. Med. 329, 1308-1313 (1993).
61. Snouwaert, J. N. et al. An animal model of cystic fibrosis made by gene targeting. Science 257, 1083-1088 (1992).
62. Dorin, J. R. et al. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 359, 211-215 (1992).
63. Zeiher, B. G. et al. A mouse model for the delta F508 allele of cystic fibrosis. J. Clin. Invest. 96, 2051-2064 (1995).
64. Colledge, W. H. et al. Cystic fibrosis mouse with intestinal obstruction. Lancet 340, 680 (1992).
65. Rozmahel, R. et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nature Genet. 12, 280-287 (1996). This study shows the importance of genetic modifiers in mouse models of human disease. It was the first example of linkage to a modifier that was discovered in mice and then replicated in humans.
66. Zielenski, J. et al. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nature Genet. 22, 128-129 (1999).
67. Beroud, C. & Soussi, T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res. 24, 121-124 (1996).
68. Moser, A. R., Pitot, H. & Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324 (1990).
69. Su, L.-K. et al. Multiple intestinal neoplsia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670 (1992).
70. Dietrich, W. F. et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75, 631-639 (1993). A classic paper on the genetics of modifier genes, which was based on genetic discoveries In mice and successfully identified a pharmacologically relevant pathway in humans.
71. Mn-induced intestinal neoplasia. Cell 81, 957-966 (1995).
72. Cormier, R. T. et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nature Genet. 17, 88-91 (1997).
73. Dobbie, Z. et al. Identification of a modifier gene locus on chromosome 1p35-36 in familial adenomatous polyposis. Hum. Genet. 99, 653-657 (1997).
74. Nimmrich, I. et al. Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP. Hum. Genet. 100, 345-349 (1997).
75. Torrance, C. J. et al. Combinatorial chemoprevention of intestinal neoplasia. Nature Med. 6, 1024-1028 (2000).
76. Taketo, M. Cyclooxygenase-2 inhibitors in tumorigenesis (Part 1). J. Natl Canc. Inst. 90, 1529-1536 (1998).
77. Taketo, M. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J. Natl Canc. Inst. 90, 1609-1620 (1998).
78. d716 knockout mice by inhibition of cyclooxygenase 2 (Cox-2). Cell 87, 803-809 (1996).
79. 2 gene. J. Biol. Chem. 275, 34013-34016 (2000).
80. Holtzman, N. A. & Marteau, T. M. Will genetics revolutionize medicine? N. Engl. J. Med. 343, 141-144 (2000).
81. Sotos, J. G. & Rienhoff, H. Y. Letter. N. Engl. J. Med. 343, 1496 (2000).
82. Block, G. D. & Aulisio, M. P. Letter. N. Engl. J. Med. 343, 1496 (2000).
83. Khoury, M. J. Letter. N. Engl. J. Med. 343, 1497 (2000).
84. Ference, B. A., Chauhan, M. S. & Izumo, S. Letter. N. Engl. J. Med. 343, 1497-1498 (2000).
85. Silvers, W. K. The Coat Colors of Mice (Springer, New York, 1979).
86. Michal, G. Biochemical Pathways (John Wiley, New York, 1998).